| scholarly article | Q13442814 |
| P50 | author | Bernice Lo | Q40854879 |
| P2093 | author name string | Susan Price | |
| Michael J Lenardo | |||
| V Koneti Rao | |||
| Richard M Siegel | |||
| Joie Davis | |||
| Madhu Ramaswamy | |||
| P2860 | cites work | Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop | Q24632569 |
| How I treat autoimmune lymphoproliferative syndrome | Q24633207 | ||
| A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome | Q28215936 | ||
| Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study | Q28270195 | ||
| Autoimmune lymphoproliferative syndrome with somatic Fas mutations | Q28285625 | ||
| ALPS-ten lessons from an international workshop on a genetic disease of apoptosis | Q33807422 | ||
| Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome | Q33944255 | ||
| Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance | Q34389314 | ||
| Specific elimination of effector memory CD4+ T cells due to enhanced Fas signaling complex formation and association with lipid raft microdomains | Q35092629 | ||
| Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. | Q35132088 | ||
| Human genetic approaches to diseases of lymphocyte activation | Q36152005 | ||
| Convergence of TCR and cytokine signaling leads to FOXO3a phosphorylation and drives the survival of CD4+ central memory T cells | Q36228932 | ||
| Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. | Q37363074 | ||
| CD95, BIM and T cell homeostasis | Q37526364 | ||
| The autoimmune lymphoproliferative syndrome: A rare disorder providing clues about normal tolerance | Q37695382 | ||
| Autoimmune lymphoproliferative syndrome due to FAS mutations outside the signal-transducing death domain: molecular mechanisms and clinical penetrance | Q39413664 | ||
| Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis | Q44455328 | ||
| Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency. | Q51037855 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis | Q74401877 | ||
| Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome | Q74595817 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 479-488 | |
| P577 | publication date | 2012-10-11 | |
| P1433 | published in | Journal of Clinical Immunology | Q6294961 |
| P1476 | title | A rapid ex vivo clinical diagnostic assay for fas receptor-induced T lymphocyte apoptosis | |
| P478 | volume | 33 |
| Q37541681 | Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction |
| Q92072033 | Flow Cytometry Contributions for the Diagnosis and Immunopathological Characterization of Primary Immunodeficiency Diseases With Immune Dysregulation |
| Q40993323 | Genomics is rapidly advancing precision medicine for immunological disorders |
| Q37670054 | Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations |
| Q64892906 | Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS). |
| Q39277444 | Restimulation-induced cell death: new medical and research perspectives. |
Search more.